Follow The Filings

Paulson & Co. Inc. John Paulson

Jersey City, NJ 20 processed 13Fs on this site, 2021 Q3 to 2026 Q2

  • $2.6B
  • 8 holdings
  • 2026 Q2
  • −17.2% QoQ
  • Top 5 92.3%

Portfolio

2026 Q2, filed 8/14/2026, 8 holdings

Top 5 92.3%, top 10 100.0%

AUM over time

2026 Q2 $2.6B −17.2% QoQ
2021 Q3: $3.5B 2021 Q3: $3.5B
Q3 2021
2021 Q4: $3.2B, −7.6% QoQ 2021 Q4: $3.2B, −7.6% QoQ
Q4
2022 Q1: $3.2B, +0.2% QoQ 2022 Q1: $3.2B, +0.2% QoQ
Q1 2022
2022 Q2: $2B, −37.6% QoQ 2022 Q2: $2B, −37.6% QoQ
Q2
2022 Q3: $1.4B, −32.6% QoQ 2022 Q3: $1.4B, −32.6% QoQ
Q3
2022 Q4: $1.1B, −18.7% QoQ 2022 Q4: $1.1B, −18.7% QoQ
Q4
2023 Q1: $1.2B, +8.3% QoQ 2023 Q1: $1.2B, +8.3% QoQ
Q1 2023
2023 Q2: $1B, −14.9% QoQ 2023 Q2: $1B, −14.9% QoQ
Q2
2023 Q3: $1.1B, +9.2% QoQ 2023 Q3: $1.1B, +9.2% QoQ
Q3
2023 Q4: $1.1B, −0.9% QoQ 2023 Q4: $1.1B, −0.9% QoQ
Q4
2024 Q1: $1.4B, +30.7% QoQ 2024 Q1: $1.4B, +30.7% QoQ
Q1 2024
2024 Q2: $1.4B, −6.6% QoQ 2024 Q2: $1.4B, −6.6% QoQ
Q2
2024 Q3: $1.4B, +5.3% QoQ 2024 Q3: $1.4B, +5.3% QoQ
Q3
2024 Q4: $1.7B, +15.9% QoQ 2024 Q4: $1.7B, +15.9% QoQ
Q4
2025 Q1: $1.7B, +5.8% QoQ 2025 Q1: $1.7B, +5.8% QoQ
Q1 2025
2025 Q2: $2B, +15.1% QoQ 2025 Q2: $2B, +15.1% QoQ
Q2
2025 Q3: $3B, +47.6% QoQ 2025 Q3: $3B, +47.6% QoQ
Q3
2025 Q4: $3.3B, +9.9% QoQ 2025 Q4: $3.3B, +9.9% QoQ
Q4
2026 Q1: $3.1B, −4.6% QoQ 2026 Q1: $3.1B, −4.6% QoQ
Q1 2026
2026 Q2: $2.6B, −17.2% QoQ 2026 Q2: $2.6B, −17.2% QoQ
Q2

Book

2025 Q1 2024 Q4, filed 15 May, long equity only

MDGL, Madrigal Pharmaceuticals 39.81%, was 38.14% Add +2.8% 2,099,523 $331.23 $695M +57,523 +$65M
PPTA, Perpetua Resources 15.16% Hold 24,771,542 $10.69 $265M — —
AAMI, Acadian Asset Management 13.25% Hold 8,950,121 $25.86 $231M — —
BHC, Bausch Health Companies 9.79% Hold 26,439,035 $6.47 $171M — —
AEM, Agnico Eagle Mines 4.86% Hold 783,561 $108.41 $85M — —
NG, Novagold Resources 4.55% Hold 27,238,061 $2.92 $80M — —
THRY, Thryv 3.14% Hold 4,280,000 $12.81 $55M — —
THM 2.54%, was 1.77% Add +9.4% 70,239,388 $0.6320 $44M +6,040,408 +$15M
HON, Honeywell 2.42% New 200,000 $211.75 $42M +200,000 +$42M
SA, Seabridge Gold 1.38% Hold 2,070,000 $11.67 $24M — —
Trilogy Metals 1.27% Hold 14,326,996 $1.55 $22M — —
EQX, Equinox Gold 0.98% Hold 2,500,000 $6.88 $17M — —
Iamgold 0.66% Hold 1,850,000 $6.25 $12M — —
Intra-Cellular Therapies 0.16% New 21,500 $131.92 $2.8M +21,500 +$2.8M

Exits / last held

Gone since 2024 Q4, shown at their last reported size.

Stock % of portfolio Recent activity Shares Reported price* Value Share change $ change
GOOGL, Alphabet 0.12% Exit 0 $190.40 $1.9M −10,000 −$1.9M

Weight bar: held both quarters added sold at this quarter’s reported price

* Reported price is value ÷ shares from the 13F as of period end, not a live market quote. Weight % is each long-equity position ÷ full 13F AUM, so rows may not sum to 100% when the filing includes options or other non-equity (excluded from this table). Share change and $ change are vs 2024 Q4. Click a column header to sort, or New, Hold, Add or Reduce to bring those moves to the top. Exit opens the last-held block below.

Filings history

20 periods, with AUM normalized

Period Holds AUM QoQ Form Filed Filing ID
2026 Q2 8 $2.6B −17.2% 13F-HR 8/14/2026 000101359426000913
2026 Q1 9 $3.1B −4.6% 13F-HR 5/15/2026 000101359426000611
2025 Q4 9 $3.3B +9.9% 13F-HR 2/17/2026 000101359426000257
2025 Q3 10 $3B +47.6% 13F-HR 11/14/2025 000101359425001436
2025 Q2 15 $2B +15.1% 13F-HR 8/14/2025 000101359425001044
2025 Q1 14 $1.7B +5.8% 13F-HR 5/15/2025 000101359425000679
2024 Q4 13 $1.7B +15.9% 13F-HR 2/14/2025 000101359425000309
2024 Q3 15 $1.4B +5.3% 13F-HR 11/14/2024 000101359424000980
2024 Q2 16 $1.4B −6.6% 13F-HR 8/14/2024 000101359424000667
2024 Q1 18 $1.4B +30.7% 13F-HR 5/15/2024 000101359424000487
2023 Q4 17 $1.1B −0.9% 13F-HR 2/14/2024 000101359424000197
2023 Q3 18 $1.1B +9.2% 13F-HR 11/14/2023 000101359423000930
2023 Q2 21 $1B −14.9% 13F-HR 8/14/2023 000101359423000696
2023 Q1 20 $1.2B +8.3% 13F-HR 5/15/2023 000101359423000494
2022 Q4 22 $1.1B −18.7% 13F-HR 2/14/2023 000101359423000262
2022 Q3 28 $1.4B −32.6% 13F-HR 11/14/2022 000156761922020074
2022 Q2 32 $2B −37.6% 13F-HR 8/15/2022 000156761922016238
2022 Q1 33 $3.2B +0.2% 13F-HR 5/16/2022 000156761922011018
2021 Q4 36 $3.2B −7.6% 13F-HR 2/14/2022 000156761922004409
2021 Q3 38 $3.5B — 13F-HR 11/15/2021 000156761921020479

About

Paulson & Co. Inc.

20 processed 13Fs on this site, 2021 Q3 to 2026 Q2

Entity
Paulson & Co. Inc.
Notable person
John Paulson
Location
Jersey City, NJ
All SEC filings
View on sec.gov